Modulation of CD11b/CD18 on monocytes and granulocytes following hemodialysis membrane interaction in vitro

International Journal of Artificial Organs

Volumn 19, Issue 3, 1996, Pages 156-163

  Thylen P ^a   Fernvik, E ^a   Lundahl, J ^a   Hed, J ^a   Jacobson, S H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Biocompatibility; CD11b CD18; Complement; Hemodialysis

Indexed keywords

BIOCOMPATIBILITY; BODY FLUIDS; COPPER; DIALYSIS MEMBRANES; HELIUM; HEMODIALYZERS;

ADHESION MOLECULES; CD11B/CD18; CLASSICAL PATHWAY; COMPLEMENT; COMPLEMENT SYSTEMS; CUPROPHAN; HAEMODIALYSIS; HUMAN SERUM; POLYSULPHONE; UP-REGULATION;

DIALYSIS;

CELL ADHESION MOLECULE; COMPLEMENT;

ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; GRANULOCYTE; HEMODIALYSIS; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN;

EID: 0029932656     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900304     Document Type: Article

References (24)

1. Arnaout MA, Hakim RM, Todd III RF, Dana N, Colten HR. Increased expression of an adhesion promoting surface glucoprotein in the granulocytopenia of hemodialysis. N EngI J Med 1985; 312: 457-62.
2. Thylén P, Lundahl J, Fernvik E, Hed J, Svenson SB, Jacobson SH. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992; 12: 393-400.
3. Himmelfarb J, Lazarus M, Hakim R. Reactive oxygene species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991: 17: 271-6.
4. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 1983; 24: 764-9.
5. Cheung AK, Parker CJ, Janatova J. Analysis of the complement C3 fragments associated with hemodialysis membranes. Kidney Int 1989; 35: 576-88.
6. Cheung AK, Parker CJ, Wilcox LA, Janatova J. Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-9.
7. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
8. Truedsson L, Sjöholm AG, Laurell A-B. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel. Acta Pathol Microbiol Scand 1981; 89: C161-6.
9. Lundahl J, Hed J, Jacobson SH. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1. Nephron 1992; 61: 163-9.
10. Larsson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 181-217.
11. Todd RF III, Arnaout MA, Rosin RE et al. Subcellular localization of the large subunit of Mo1 (Mo1 alpha, formerly gp 110) a surface glycoprotein associated with neutrophil adhesion. J Clin Invest 1984; 74: 1280-90.
12. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumour necrosis factor. Proc Natl Acad Sci (USA) 1985; 82: 8667-71.
13. Bommer J, Becker KP, Urbaschek R, Ritz E, Urbaschek B. No evidence for endotoxin transfer across high flux polysulfone membranes. Clin Nephrol 1987; 27: 278-82.
14. Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p 150.95 adhesion proteins from an intracellular vesicular compartments to the cell surface. J Clin Invest 1987; 80: 535-44.
15. Tielemans CL, Delville J-PC, Husson CP, et al. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993; 39: 158-65.
16. Cheung AK, Chenoweth DE, Otsuka D, Henderson LW. Compartmental distribution of complement activation products in artificial kidneys. Kidney Int 1986; 30: 74-80.
17. Cheung AK, Parker CJ, Wilcox L, Janatova J. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int 1989; 36: 257-65.
18. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Cain Invest 1977; 59: 879-88.
19. Reid KBM, Porter RR. The proteolytic activation systems of complement. Ann Rev Biochem 1981; 50: 433-64.
20. Maillet F, Kazatchkine MD. Specific antibodies enhance alternative complement pathway activation by cuprophane. Nephrol Dial Transplant 1991; 6: 193-7.
21. Hakim RM, Wingard RL, Parker RA, Vanholder R, Husni L, Parker III TF. Effects of biocompatibility on hospitalisations and infectious morbidity in chronic hemodialysis patients. JASN 1994; 5: 450 (abstract).
22. Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. JASN 1992; 3: 1227-1237.
23. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344: 570-2.
24. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-42.